Rachel Vatnsdal

Stock Analyst at JP Morgan

(0.12)
# 1836
Out of 5,291 analysts
63
Total ratings
46.34%
Success rate
6.24%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
Envista Holdings
Maintains: Neutral
20 19
16.96 12.03% 4 Mar 6, 2025
Waters
Maintains: Neutral
380 390
361.6 7.85% 4 Mar 6, 2025
Tempus AI
Downgrades: Neutral
50 55
47.87 14.89% 3 Feb 25, 2025
Repligen
Maintains: Overweight
190 200
133.41 49.91% 5 Feb 21, 2025
Guardant Health
Maintains: Overweight
50 55
43.1 27.61% 1 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
14 12
9.18 30.72% 3 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
35 40
40.27 -0.67% 1 Feb 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
165 160
116.59 37.23% 6 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
650 670
499.72 34.08% 8 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
88 80
68.59 16.64% 3 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
17 20
8.87 125.48% 3 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1300 1400
1176.24 19.02% 2 Aug 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 6
7.67 -21.77% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
105 120
105.68 13.55% 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
60 90
42.06 113.98% 2 Feb 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
250 270
205.69 31.27% 4 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
90 45
n/a n/a 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
n/a
n/a n/a 2 Nov 10, 2022